Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velt, P. M.
Right arrow Articles by Link, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velt, P. M.
Right arrow Articles by Link, R. J.

Radiology, Vol 153, 91-93, Copyright © 1984 by Radiological Society of North America

ARTICLES

Transjugular liver biopsy in high-risk patients with hepatic disease

PM Velt, OG Choy, PM Shimkin and RJ Link

Records were reviewed of 160 patients who underwent transjugular liver biopsy (TJLB) during a five-year period. Percutaneous transperitoneal needle biopsy was contraindicated in 95% of these patients because of coagulation abnormalities or massive ascites. Moderate complications occurred in two patients. Diagnostic biopsy material was obtained in 129 (81%). TJLB provided useful information in 44 of 58 patients without documented alcohol abuse (clinical Groups III and IV). TJLB disclosed additional diagnoses aside from Laennec cirrhosis in 15 of 48 alcoholic patients with sudden clinical deterioration (Group II), including 11 cases with other stages of alcholic liver disease and four cases of primary or metastatic neoplasm. TJLB revealed diagnoses other than Laennec cirrhosis, including three neoplasms, in six of 54 clinically stable alcoholics (Group I). TJLB frequently yielded important data relative to clinical management or prognosis in Group II, III, and IV patients; it was less useful in Group I patients.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
K. W. Kim, M.-J. Kim, H.-C. Kim, S. H. Park, S. Y. Kim, M.-S. Park, and T. K. Kim
Value of "Patent Track" Sign on Doppler Sonography After Percutaneous Liver Biopsy in Detection of Postbiopsy Bleeding: A Prospective Study in 352 Patients
Am. J. Roentgenol., July 1, 2007; 189(1): 109 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. Habdank, R. Restrepo, V. Ng, B. L. Connolly, M. J. Temple, J. Amaral, and P. G. Chait
Combined Sonographic and Fluoroscopic Guidance During Transjugular Hepatic Biopsies Performed in Children: A Retrospective Study of 74 Biopsies
Am. J. Roentgenol., May 1, 2003; 180(5): 1393 - 1398.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1984 by the Radiological Society of North America.